Analysis Vanda Pharmaceuticals Inc. (0LKB)
6/5/2024
Analysis of Vanda Pharmaceuticals Inc. (0LKB)
Vanda Pharmaceuticals Inc. (0LKB) has shown some volatility in its stock price over the past few days. The Relative Strength Index (RSI) values have been fluctuating around the 50 mark, indicating a balanced market sentiment without a clear trend.The Moving Average Convergence Divergence (MACD) indicator has been hovering around the zero line, suggesting a lack of strong momentum in either direction. The MACD histogram has been mostly negative, indicating some bearish pressure.
The stock's closing prices have been moving within a range, with some days showing slight gains and others slight losses. The Simple Moving Average (SMA) and Exponential Moving Average (EMA) have been close to each other, reflecting the sideways movement in the stock price.
Overall, Vanda Pharmaceuticals Inc. seems to be consolidating with no clear direction in the short term. Traders and investors may need to wait for a clearer trend to emerge before making significant trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The average trading volume is 46.86 million shares over 10 days and 57.50 million shares over 90 days. The stock outstanding is 15.33 billion shares, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65. The enterprise to EBITDA ratio is 22.76 and the enterprise to revenue ratio is 7.73. The market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.26, a 50-day moving average of $176.26, a 200-day moving average of $181.04, a 52-week low of $164.08, a 52-week high of $199.62, and a 52-week change of 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential decrease in profit margins.
3. The company's gross profit has fluctuated over the years, reaching its peak in 2023 at $169.1 billion.
4. Operating income has shown an upward trend, reaching $114.3 billion in 2023.
5. Net income has also been increasing annually, reaching $97 billion in 2023.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been stable over the years.
7. The company has been able to maintain a consistent number of outstanding shares, which is important for investors.
8. Overall, the financial performance of the company seems to be positive, with increasing revenues and profits over the years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate for the next year is expected to increase to 9.7%.
5. Past 5 Years (per annum): Over the past 5 years, the company has shown a growth rate of approximately 20.1% per year.
6. Next 5 Years (per annum): Looking ahead, analysts project a growth rate of around 9.7% per year for the next 5 years.
These estimates suggest a positive outlook for the company, with a gradual increase in growth rate expected in the upcoming periods compared to the current and previous years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of estimates, from a low of $164 to a high of $275, indicating some uncertainty in the predictions.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to finance its operations over the years.
7. There is a need to monitor the current liabilities as they have been fluctuating.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This indicates growth from the EPS of $5.67 in the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a potential increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and the next fiscal years.
MACD of 0LKB
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
